Market Overview

UPDATE: Jefferies Raises PT on Accuray Following Good F4Q Results

Related ARAY
Earnings Scheduled For August 21, 2014
What Falling Estimates & Price Mean for Oxford Immunotec Global (OXFD) - Tale of the Tape

In a report published Wednesday, Jefferies analyst Raj Denhoy reiterated a Buy rating on Accuray (NASDAQ: ARAY), and raised the price target from $6.50 to $8.00.

In the report, Jefferies noted, “ARAY posted a good F4Q with a modest revenue beat, tighter expense controls, and another sequential uptick in bookings. Initial F14 guidance calls for continued order momentum albeit with a slightly higher opex run-rate. The continued bookings resurgence coupled with cost controls make the still distressed valuation increasingly unsustainable. We stay at Buy and PT goes to $8.”

Accuray closed on Tuesday at $6.10.

Latest Ratings for ARAY

DateFirmActionFromTo
Jun 2014JP MorganUpgradesNeutralOverweight
Mar 2014BTIG ResearchInitiates Coverage onBuy
Jan 2014JP MorganMaintainsNeutral

View More Analyst Ratings for ARAY
View the Latest Analyst Ratings

Posted-In: Jefferies Raj DenhoyAnalyst Color Price Target Analyst Ratings

 

Related Articles (ARAY)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters